Menu Search
Equities

Archer Materials Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
38A:FRA

Archer Materials Ltd

Actions
  • Price (EUR)0.232
  • Today's Change0.02 / 9.43%
  • Shares traded17.00k
  • 1 Year change+7.41%
  • Beta0.4251
Data delayed at least 15 minutes, as of Feb 16 2026 15:32 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Archer Materials Limited is a quantum technology company building advanced semiconductor devices for quantum computing, quantum sensing, and medical diagnostics. The Company principal activities include technology research and development of the carbon nano onion quantum material (12CQ Project), tunnelling magnetoresistance (TMR) sensor project and graphene-based lab-on-a-chip biosensing chip (biochip) and utilizing semiconductor technology development infrastructure and facilities, research, and development to support technology research and development. The Company is focused on developing its biochip technology, including identifying and developing testing for blood potassium levels, for its first target of hypo- and hyperkalemia detection in chronic kidney disease (CKD) patients. Its biochip marks an inflection point in diagnostics, enabling fast, accurate, and low-cost digital testing.

  • Revenue in AUD (TTM)0.00
  • Net income in AUD-6.97m
  • Incorporated2007
  • Employees8.00
  • Location
    Archer Materials LtdLot Fourteen, Frome RoadADELAIDE 5000AustraliaAUS
  • Phone+61 88272-3288
  • Fax+61 88272-3888
  • Websitehttps://archerx.com.au/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.